Diterpenoid alkaloids: toxic and therapeutic
Diterpenoid alkaloids represent a structurally complex, intersecting class of specialized plant metabolites of immense pharmaceutical interest. Chemically, these structures exist at the junction of two distinct natural product classes, featuring a core diterpene carbon scaffold that incorporates a nitrogen atom and undergoes extensive downstream enzymatic modifications. Primarily localized within the Ranunculaceae family1,2—most notably in the genera Aconitum (wolfsbane) and Delphinium (larkspur)—these compounds possess a rich history in traditional medicine and have been documented in therapeutic applications for over 2,000 years to alleviate severe pain, rheumatism, and cardiovascular disorders1,3. Modern pharmacological studies are exploring these scaffolds for developing new anti-cancer therapeutics and cardiac medications. However, because the wild-type natural products possess extreme systemic toxicity, chemical modification via synthesis is vital to decouple their medicinal utility from lethal side effects.
From plant extraction to chemical synthesis to bio-manufacturing
Acquiring diterpenoid alkaloids at a commercially viable scale presents a severe bottleneck for drug development. Direct extraction from wild plant tissues is highly inefficient, environmentally unsustainable, and hazardous; plants produce these intricate molecules in trace quantities primarily as chemical defense mechanisms against herbivores.
Concurrently, total chemical synthesis of diterpenoid alkaloids is practically unfeasible due to their extreme structural complexity. A prime example is aconitine, a highly bioactive alkaloid containing six interconnected rings and 15 stereocenters. Despite its initial isolation in 1833, aconitine’s structural complexity has prevented successful de novo chemical synthesis to this day4.
Biological synthesis represents the most viable alternative for scalable production. This biosynthesis requires discovering the exact enzymatic steps and introducing them into fast-growing hosts like baker’s yeast or tobacco plants (Nicotiana benthamiana).
Solving the synthesis puzzle
The exact biological pathway that plants use to make diterpenoid alkaloids has largely been a mystery. While scientists had previously figured out some of the early steps involving terpene formation, the pivotal transition step—the precise enzyme responsible for incorporating nitrogen into the diterpene scaffold to officially create the alkaloid—remained unknown.
In a recent study, a research team from the US and Czechia addressed this gap by deploying comparative transcriptomics and advanced computational metabolomics to resolve the entry steps of diterpenoid alkaloid biosynthesis5. They team aimed to identify the specific enzymes responsible for generating the initial diterpene scaffold and characterize the exact enzyme(s) mediating nitrogen incorporation into the scaffold, marking the transition from diterpenoids to diterpenoid alkaloids. Furthermore, the study sought to determine the preferred physiological source of nitrogen for these metabolites (e.g., ethylamine vs. ethanolamine). Ultimately, the authors aimed to reconstruct a minimal biosynthetic pathway sufficient for the de novo production of the foundational alkaloid atisinium.
Computational Metabolomics via SIRIUS Unlocks Nitrogen Tracking
To trace the biosynthetic pathway, Aconitum plicatum callus cultures were subjected to stable isotope feeding experiments. Physical standards and comprehensive spectral libraries for diterpenoid alkaloids are remarkably scarce. Thus, the team utilized SIRIUS within their untargeted LC-MS/MS pipeline to systematically annotate molecular formulas (with formula rankings subsequently refined using the ZODIAC module) and predict compound classes.
By isolating the high-probability terpenoid alkaloid features identified by SIRIUS compound class prediction, the team successfully monitored the outcomes of their stable isotope feeding experiments. The data revealed that 41 detected alkaloids exclusively incorporated deuterium-labeled isotopologues during ethanolamine-feeding conditions. This yielded a major scientific discovery: ethanolamine, rather than ethylamine, acts as the primary nitrogen source for a wide range of diverse diterpenoid alkaloids. This finding was highly unexpected, given that an ethylamine moiety is prominent in the final chemical structures of many well-known compounds in this class, including complex molecules like aconitine.
Building on this, the team successfully elucidated six conserved enzymatic steps—including the discovery of a novel reductase (DAS)—that form a minimal biosynthetic pathway sufficient for the de novo production of the foundational diterpenoid alkaloid atisinium.
Groundwork for scalable bio-manufacturing of diterpenoid alkaloid therapeutics
This study unlocks the biological production of diterpenoid alkaloids, by resolving the missing link in plant specialized metabolism: the nitrogen-incorporating mechanism of the diterpenoid alkaloid pathway. By demonstrating that ethanolamine is the preferred biological nitrogen donor and defining the six core enzymatic steps required to build atisinium, this work provides the foundational genetic architecture necessary to bypass traditional extraction limits. Ultimately, these insights lay the groundwork for scalable bio-manufacturing and metabolic engineering of complex, high-value therapeutic agents.
References
- E Nyirimigabo, Y Xu, Y Li, Y Wang, K Agyemang, Y Zhang. A review on phytochemistry, pharmacology and toxicology studies of Aconitum. J. Pharm. Pharmacol. (2015) https://doi.org/10.1111/jphp.12310 ↩︎
- T Yin, L Cai, Z Ding. An overview of the chemical constituents from the genus Delphinium reported in the last four decades. RSC Adv. (2020) https://doi.org/10.1039/D0RA00813C ↩︎
- Y Li, F Gao, J-F Zhang, X-L Zhou. Four New Diterpenoid Alkaloids from the Roots of Aconitum carmichaelii. Chem. Biodivers. (2018) https://doi.org/10.1002/cbdv.201800147 ↩︎
- R-J Zhou, G-Y Dai, X-H Zhou, M-J Zhang, P-Z Wu, D Zhang, H Song, X-Y Liu, Y Qin. Progress towards the synthesis of aconitine: construction of the AE fragment and attempts to access the pentacyclic core. Org. Chem. Front. (2019) https://doi.org/10.1039/c8qo01228h ↩︎
- GP Miller, L Mutabdžija-Nedelcheva, TB Andersen, I Pascoe, K Van Winkle, M Sabbaghan, A Bouille, T Iliaš Tekel, T Pluskal, B Hamberger. Characterization of the Entry Steps in Diterpenoid Alkaloid Biosynthesis. Mol. Plant (2026) https://doi.org/10.1016/j.molp.2026.05.022
↩︎
